US2021322557A1PendingUtilityA1

Hydrolytically degradable polysaccharide hydrogels

Assignee: UNIV PENNSYLVANIAPriority: Dec 22, 2008Filed: Jun 23, 2021Published: Oct 21, 2021
Est. expiryDec 22, 2028(~2.4 yrs left)· nominal 20-yr term from priority
A61L 2300/442A61L 27/3834C12N 5/0663A61L 27/54A61L 2300/426C12N 2533/80C12N 2533/40A61K 47/36C12N 5/0012A61L 2300/414A61L 27/18A61L 27/52A61L 27/58A61L 2300/604A61L 2430/06
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are polysaccharide compositions capable of controllable hydrolytic degradation and suitable for controlled release of therapeutic agents. Also provided are methods for synthesizing such compositions and a variety of applications in which the compositions may be used.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A composition, comprising:
 a polymer comprising a plurality of repeat units,   at least one repeat unit comprising
 a biocompatible backbone comprising a polysaccharide; 
 a hydrolytically degradable linker; and 
 a crosslinker, 
   the hydrolytically degradable linker being disposed between the biocompatible backbone and the crosslinker group,   the hydrolytically degradable linker degrading upon exposure to an aqueous medium, and   the crosslinker group covalently binding at least one repeat unit to a second repeat unit.   
     
     
         2 . The composition of  claim 1 , wherein the hydrolytically degradable linker comprises at least one ester. 
     
     
         3 . The composition of  claim 1 , wherein the hydrolytically degradable linker comprises lactic acid, caprolactone, or glycolic acid. 
     
     
         4 . The composition of  claim 3 , wherein the hydrolytically degradable linker comprises lactic acid. 
     
     
         5 . The composition of  claim 1 , wherein the crosslinker comprises a crosslinking product of an acryl or a methacryl moiety. 
     
     
         6 . The composition of  claim 1 , further comprising one or more cells disposed therein or thereon. 
     
     
         7 . The composition of  claim 6 , wherein a cell comprises a mammalian cell. 
     
     
         8 . The composition of  claim 6 , wherein a cell comprises a stem cell. 
     
     
         9 . The composition of  claim 1 , further comprising one or more agents disposed therein. 
     
     
         10 . The composition of  claim 9 , wherein an agent comprises a therapeutic agent, a marker, a label, a dye, or any combination thereof. 
     
     
         11 . The composition of  claim 1 , wherein the composition comprises two repeat units that differ in the composition of their hydrolytically degradable linkers. 
     
     
         12 . The composition of  claim 1 , wherein the composition comprises two repeat units that differ in the composition of their biocompatible backbones. 
     
     
         13 . The composition of  claim 1 , wherein the composition comprises two repeat units that differ in the composition of their crosslinkers. 
     
     
         14 . The composition of  claim 1 , wherein the polysaccharide comprises hyaluronic acid. 
     
     
         15 . A macromer, comprising
 a biocompatible backbone comprising a polysaccharide;   a hydrolytically degradable linker; and   a polymerizable crosslinker;   the hydrolytically degradable linker being disposed between the biocompatible backbone and the crosslinker group,   the hydrolytically degradable linker degrading upon exposure to an aqueous medium, and   the crosslinker comprising a carbon-carbon double bond.   
     
     
         16 . The macromer of  claim 14 , wherein the hydrolytically degradable linker comprises at least one ester. 
     
     
         17 . The macromer of  claim 14 , wherein the hydrolytically degradable linker comprises lactic acid, caprolactone, or glycolic acid. 
     
     
         18 . The macromer of  claim 14 , wherein the crosslinker comprises an acrylate or a methacrylate moiety. 
     
     
         19 . The macromer of  claim 14 , wherein a polysaccharide comprises hyaluronic acid. 
     
     
         20 . The macromer of  claim 14 , wherein the hydrolytically degradable linker and the crosslinker together define the following structure:

Join the waitlist — get patent alerts

Track US2021322557A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.